checkAd
    BioRestorative Therapies Aktie
    1,1800
     
    EUR
    +0,85 %
    +0,0100 EUR
    Letzter Kurs 15:29:01 Frankfurt
    1,1700
     
    EUR
    1.709 STK
    Geldkurs 20:03:04
    1,3300
     
    EUR
    1.501 STK
    Briefkurs 20:18:03
    ISIN: US0906556065 · WKN: A3C9XF · SYM: 9OF · USA

    Neueste Nachrichten

    BioRestorative Therapies Provides First Quarter 2024 Business Update
    14.05.24 · globenewswire · BioRestorative Therapies
    BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity
    08.05.24 · globenewswire · BioRestorative Therapies
    BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
    30.04.24 · globenewswire · BioRestorative Therapies
    BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology
    30.04.24 · globenewswire · BioRestorative Therapies
    BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
    16.04.24 · globenewswire · BioRestorative Therapies
    BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease
    08.04.24 · globenewswire · BioRestorative Therapies
    BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants
    03.04.24 · globenewswire · BioRestorative Therapies
    BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K
    01.04.24 · globenewswire · BioRestorative Therapies
    BioRestorative Therapies to Participate in the 36th Annual ROTH Conference
    11.03.24 · globenewswire · BioRestorative Therapies
    BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market
    06.02.24 · globenewswire · BioRestorative Therapies
    BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
    05.02.24 · globenewswire · BioRestorative Therapies
    BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting
    01.02.24 · globenewswire · BioRestorative Therapies